Lars Dyrskjøt

34PUBLICATIONS
188CO-AUTHORS
Obstetrics and gynaecologyGene expression (incl. microarray and other genome-wide approaches)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Apr 13, 2026
Plasma proteomic signature of the human menstrual cycle.

Iben Riishede, Line Rode, Pia Rengtved Lundegaard

|Mar 25, 2026
Cell-Free DNA-Derived Immune Cell Ratios Uncover Cancer-Associated Systemic Changes.

Laura Andersen, Sia V Lindskrog, Iver Nordentoft

|Mar 19, 2026
Thymic health and immunotherapy outcomes in patients with cancer.

Simon Bernatz, Vasco Prudente, Suraj Pai

|Jan 22, 2026
ctDNA-guided treatment decisions in muscle-invasive bladder cancer.

Lars Dyrskjøt

|Nov 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell types.

Ludvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting

|Oct 27, 2025
Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer.

Lars Dyrskjøt, Peter Black, Seth Lerner

Pageof 6